We have determined that Aurora kinase targeting in KRAS-positive lung cancer cells leads to loss of viability through promoting cell cycle arrest at G2 and through activation of apoptosis (Figs. 2d–e and 3d–e). The gene discussed is KRAS; the disease is lung cancer.